Dossier Pharmaceuticals Private Limited
About Dossier Pharmaceuticals Private Limited
Data last updated:
Dossier Pharmaceuticals Private Limited was a private limited company based in Pune, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 28 June 2013.
The company was registered with the Registrar of Companies (ROC), Pune, under CIN U24233PN2013PTC147925. Its GSTIN is 27AAECD7344K1ZD (Maharashtra).
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Sandip Sheshrao Dandale and Soham Shesharao Dandale.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at Fl No. B – 203 Ganraj Terrace Mohamadwadi S 59/1A Opp Desai Hospital Hadapsar, Pune, Maharashtra, India – 411028.
As per the financials filed for FY 2018, the company reported a revenue of ₹12.07 Lakh, a growth of 108% compared to the previous year. For the same year it recorded a net profit of ₹29,028 (net margin 2.4%) and EBITDA of ₹43,249 (EBITDA margin 3.6%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years.
Company details
Contact details
Dossier Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFl No. B – 203 Ganraj Terrace Mohamadwadi S 59/1A Opp Desai Hospital Hadapsar, Pune, Maharashtra, India – 411028
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Dossier Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dossier Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Dossier Pharmaceuticals Private Limited, buy the company report.
Financials of Dossier Pharmaceuticals Private Limited
FY 2018 filings availableDossier Pharmaceuticals Private Limited reported revenue of ₹12.07 Lakh (up 108% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 30% over three years, including 108% growth in the latest year. EBITDA rose 192% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹43,249 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹29,028 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 3.6% | |||
| Net Profit Margin | 2.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Dossier Pharmaceuticals Private Limited, buy the company report.
Board of directors of Dossier Pharmaceuticals Private Limited
Dossier Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandip Sheshrao Dandale | Director | 28 Jun 2013 | 13 Years 4 Months | As last reported |
| Soham Shesharao Dandale | Director | 28 Jun 2013 | 13 Years 4 Months | As last reported |
Auditor
Dossier Pharmaceuticals Private Limited is audited by Y.A. Kshirsagar & Co. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Y.A. Kshirsagar & Co. | FY 2017 | 137989W |
Shareholding
The shareholding of Dossier Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Dossier Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Dossier Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dossier Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dossier Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECD7344K1ZD | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dossier Pharmaceuticals Private Limited, buy the company report.
Recent activity
Dossier Pharmaceuticals Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Sandip Sheshrao Dandale was appointed as Director on 28 Jun 2013.
Frequently asked questions
Dossier Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Dossier Pharmaceuticals was a private limited company based in Pune, Maharashtra, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 28 June 2013 and is registered under CIN U24233PN2013PTC147925. The company has been struck off by the Registrar of Companies and is no longer operational.
Dossier Pharmaceuticals had 2 directors:
- Sandip Sheshrao Dandale - Director
- Soham Shesharao Dandale - Director
The CIN (Corporate Identification Number) of Dossier Pharmaceuticals is U24233PN2013PTC147925. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Dossier Pharmaceuticals is at Fl No. B – 203 Ganraj Terrace Mohamadwadi S 591A Opp Desai Hospital Hadapsar, Pune, Maharashtra, India – 411028.
Dossier Pharmaceuticals was incorporated on 28 June 2013. It is registered with the Registrar of Companies, Pune.
The latest financial statements of Dossier Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from 2015 are in the company report.
The GSTIN of Dossier Pharmaceuticals is 27AAECD7344K1ZD, registered in Maharashtra.
Dossier Pharmaceuticals operated in the chemicals industry, in the medicinal chemical and botanical products segment. It worked in this industry before it was struck off.
Sandip Sheshrao Dandale was appointed as Director on 28 Jun 2013. Soham Shesharao Dandale was appointed as Director on 28 Jun 2013.